Bio-Rad Laboratories Current Ratio 2010-2022 | BIO.B

Current and historical current ratio for Bio-Rad Laboratories (BIO.B) from 2010 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Bio-Rad Laboratories current ratio for the three months ending September 30, 2022 was 5.50.
Bio-Rad Laboratories Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2022-09-30 $3.14B $0.57B 5.50
2022-06-30 $3.25B $0.61B 5.30
2022-03-31 $3.30B $0.65B 5.10
2021-12-31 $1.99B $0.68B 2.92
2021-09-30 $2.47B $0.65B 3.80
2021-06-30 $2.29B $0.59B 3.90
2021-03-31 $2.18B $0.61B 3.57
2020-12-31 $2.14B $0.63B 3.39
2020-09-30 $2.32B $0.99B 2.36
2020-06-30 $2.13B $0.93B 2.30
2020-03-31 $2.08B $0.87B 2.40
2019-12-31 $2.18B $0.91B 2.41
2019-09-30 $2.05B $0.43B 4.72
2019-06-30 $2.09B $0.45B 4.68
2019-03-31 $2.03B $0.44B 4.57
2018-12-31 $2.02B $0.45B 4.49
2018-09-30 $2.03B $0.45B 4.49
2018-06-30 $1.99B $0.44B 4.50
2018-03-31 $1.98B $0.46B 4.33
2017-12-31 $1.98B $0.50B 3.93
2017-09-30 $1.89B $0.47B 4.06
2017-06-30 $1.83B $0.46B 4.01
2017-03-31 $1.73B $0.41B 4.25
2016-12-31 $1.85B $0.47B 3.91
2016-09-30 $1.85B $0.44B 4.18
2016-06-30 $1.81B $0.41B 4.40
2016-03-31 $1.78B $0.40B 4.43
2015-12-31 $1.78B $0.44B 4.03
2015-09-30 $1.79B $0.44B 4.12
2015-06-30 $1.74B $0.40B 4.31
2015-03-31 $1.70B $0.42B 4.08
2014-12-31 $1.72B $0.45B 3.84
2014-09-30 $1.76B $0.50B 3.50
2014-06-30 $1.77B $0.48B 3.68
2014-03-31 $1.77B $0.48B 3.67
2013-12-31 $1.76B $0.49B 3.61
2013-09-30 $1.68B $0.46B 3.62
2013-06-30 $1.90B $0.43B 4.41
2013-03-31 $1.87B $0.45B 4.18
2012-12-31 $1.94B $0.47B 4.10
2012-09-30 $1.85B $0.43B 4.26
2012-06-30 $1.81B $0.42B 4.34
2012-03-31 $1.82B $0.44B 4.09
2011-12-31 $1.80B $0.46B 3.92
2011-09-30 $1.88B $0.42B 4.52
2011-06-30 $1.89B $0.44B 4.27
2011-03-31 $1.80B $0.43B 4.20
2010-12-31 $1.98B $0.67B 2.96
2010-09-30 $1.65B $0.41B 4.02
2010-06-30 $1.56B $0.39B 3.99
2010-03-31 $1.54B $0.40B 3.88
2009-12-31 $1.56B $0.42B 3.72
2009-09-30 $1.50B $0.42B 3.62
2009-06-30 $1.40B $0.38B 3.64
2009-03-31 $1.05B $0.36B 2.95
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $12.069B $2.923B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $171.581B 10.47
GSK (GSK) United Kingdom $71.504B 8.96
QIAGEN (QGEN) Netherlands $11.167B 19.06
Ginkgo Bioworks Holdings (DNA) United States $3.492B 0.00
Myovant Sciences (MYOV) United Kingdom $2.595B 0.00
Arcus Biosciences (RCUS) United States $2.459B 36.91
Biohaven (BHVN) United States $1.112B 0.00
Emergent Biosolutions (EBS) United States $0.588B 4.62
Zymeworks (ZYME) Canada $0.480B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.270B 0.00
Enzo Biochem (ENZ) United States $0.092B 0.00
SQZ Biotechnologies (SQZ) United States $0.042B 0.00
Gelesis Holdings (GLS) United States $0.032B 0.00
Ambrx Biopharma (AMAM) United States $0.020B 0.00